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Ltd. This is an open access article undAbstract Objective: To evaluate the Weill Cornell Medical College (WCMC)/New York Presby-
terian Hospital (NYPH) experience with intraoperative frozen (IOF) section in the management
of thyroid nodules with a fine needle aspiration (FNA) diagnosis of Bethesda IIeVI and to
analyze the cost and pathology benefit it provides.
Methods: The surgical and cytopathology files at WCMC/NYPH were searched within the time
period of January 2008 to May 2013. A total of 435 thyroid specimens were identified for which
both an FNA and subsequent IOF section was performed. The FNA was correlated with the lo-
cations of the resected nodule and the nodule frozen for intraoperative diagnosis. The results
of the FNA were compared to the IOF section diagnosis and final diagnosis (FD).962 2286; fax: þ1 646 962 0030.
nell.edu (M.A. Cohen).
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6 M.A. Cohen et al.Results: Among 435 cases, the FNA diagnosis was Bethesda II: 149 cases, Bethesda III: 170
cases, Bethesda IV: 91 cases, Bethesda V: 19 cases, and Bethesda VI: 6 cases. There were
a total of 83 carcinomas identified on FD, which included 69 papillary thyroid carcinomas
(PTCs), 12 follicular carcinomas, and 2 poorly differentiated carcinomas. The preoperative
FNA diagnosis for these carcinomas was as follows: Bethesda II, 11/149 (7.4%), Bethesda
III, 24/170 (14%), Bethesda IV, 26/91 (29%), Bethesda V, 16/19 (84%), and Bethesda VI,
6/6 (100%). IOF section contributed to the diagnosis of malignancy in 16/429 (4%) cases:
1/149 (0.7%) Bethesda II, 5/170 (3%) Bethesda III, 2/91 (1.1%) Bethesda IV, and 8/19 (42%)
Bethesda V. The diagnosis of malignancy was confirmed in the 6 Bethesda VI cases by IOF
section. There were no false positives on IOF section. IOF had a sensitivity and specificity
of 26% and 100%, respectively.
Conclusion: The role of IOF section is limited in the evaluation of thyroid nodules. IOF sec-
tion is most useful for nodules with an FNA diagnosis of Bethesda V lesions. The diagnosis of
follicular variant of PTC remains difficult on frozen section.
Copyright ª 2015 Chinese Medical Association. Production and hosting by Elsevier B.V. on
behalf of KeAi Communications Co., Ltd. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Table 1 The Bethesda system for reporting thyroid cyto-
pathology, adapted from Cibas and Ali.5
Bethesda category
I Nondiagnostic or unsatisfactory
Cyst fluid only
Virtually acellular neoplasm
II Benign
Benign follicular nodule (adenomatoid nodule, colloid
nodule, etc.)
Lymphocytic (Hashimoto) thyroiditis
Granulomatous (subacute) thyroiditis
III Atypia of undetermined significance or Follicular lesion
of undetermined significance
IV Follicular neoplasm or Suspicious for a follicular
neoplasm
Hu¨rthle cell (oncocytic) type
V Suspicious for malignancy
Suspicious for papillary carcinoma
Suspicious for medullary carcinoma
Suspicious for metastatic carcinoma
Suspicious for lymphoma
VI Malignant
Papillary thyroid carcinoma
Poorly differentiated carcinoma
Medullary thyroid carcinoma
Anaplastic carcinoma
Squamous cell carcinoma
Carcinoma with mixed features
Metastatic carcinoma
Non-Hodgkin lymphomaIntroduction
Affecting 4%e7% of the general population, palpable thy-
roid nodules are common.1 The incidence of thyroid cancer
has nearly tripled from 4.9 to 14.3 per 100,000 individuals
over a thirty-five year period ending in 2009.2 Such a high
incidence mandates a cost-effective and efficient method
for the preoperative evaluation of thyroid nodules. Fine
needle aspiration (FNA) has emerged as a cornerstone
modality in the preoperative management of thyroid le-
sions because of its reported high accuracy, specificity,
cost-utility and low false negative rate. The widespread
utilization of FNA has driven a significant reduction in un-
necessary thyroidectomies worldwide as well as a decrease
in the use of intraoperative frozen (IOF) sections.3 In many
cases, FNA provides a definitive benign or malignant diag-
nosis and effectively facilitates the planning of surgical and
therapeutic treatment. Among thyroid nodules that un-
dergo FNA, about 65% are classified as benign, 8% as ma-
lignant, and 3% as suspicious for malignancy.4
Nevertheless, there are several limitations of thyroid
FNA due to the nature of the procedure, the large variety of
pathologies that may arise in the thyroid glanddsome of
which cannot be diagnosed based on cytologic features
alonedand the subjectivity inherent to the interpretation
of samples. Inspired by the Bethesda system for reporting
cervical cytology widely used for reporting Pap smear re-
sults, the Bethesda Criteria for Reporting Thyroid Cytopa-
thology were published in 2009 in order to help standardize
FNA reporting (Table 1).5 Importantly, the system also
recommends supplemental studies such as immunohisto-
chemistry and molecular analysis that may aid in diagnosis,
links each of the six diagnostic categories to an implied risk
of malignancy, and provides clinical management guide-
lines ranging from clinical surveillance to near-total
thyroidectomy.5
Although FNA is most often the diagnostic modality of
choice in the management of thyroid nodules, the results
are indeterminate (classified as “unsatisfactory”, “atypical
cellular lesions”, “follicular neoplasm”, or “suspicious formalignancy”) in about 30% of cases.4 FNA is especially
inadequate at distinguishing between follicular adenoma
and follicular carcinoma because the determination of
malignancy for follicular lesions requires histologic evi-
dence of vascular and/or capsular invasion.6 In cases of
thyroidectomy, IOF section is often used to aid further
Table 2 Stratification of FNA biopsies according to
Bethesda system.
Bethesda category No. of cases
II Benign 149
III Atypia of undetermined significance
or follicular lesion of undetermined
significance
170
IV Follicular neoplasm or suspicious for
a follicular neoplasm
91
V Suspicious for malignancy 19
VI Malignant 6
Total 435
The Weill Cornell Medical College experience 7surgical decision-making at the operating table but its
usefulness in the management of thyroid nodules after an
FNA has already been performed continues to be debated.
Some previous studies do not support the use of IOF
section especially when the FNA is interpreted as a
Bethesda 4 (“follicular neoplasm or suspicious for a follic-
ular neoplasm”) or 5 (“suspicious for malignancy”) sec-
ondary to concerns regarding increased cost and operative
time7e9 while others support the use of IOF section to
confirm malignant FNA reports, to detect false-positive
FNAs and to evaluate thyroid nodules with indeterminate
cytologies.1,10 Those who support the use of IOF section at
the time of hemithyroidectomy emphasize its potential to
help surgeons avoid unnecessary staged completion thy-
roidectomy.11 Notably, most previous studies evaluating the
utility of FNA and IOF section in the management of thyroid
nodules were performed prior to the establishment of the
Bethesda system for reporting thyroid FNAs. The objective
of this study was to evaluate our institutional experience
with IOF section in the management of thyroid nodules with
a FNA diagnosis of Bethesda IIeVI and to consider the cost
and pathology benefit it provides.Table 3 Types of thyroid carcinomas identified on FD.
Tumor type No. of cases
Papillary thyroid carcinoma,
follicular variant
43
Papillary thyroid carcinoma, classical type 19
Follicular carcinoma 12
Papillary thyroid carcinoma, oncocytic type 3
Papillary thyroid carcinoma, solid variant 2
Poorly differentiated thyroid carcinoma 2
Papillary thyroid carcinoma, cribriform
morular variant
1
Papillary thyroid carcinoma, diffuse
sclerosing variant
1
Total 83Materials and methods
This retrospective assessment was approved by the WCMC
Institutional Review Board. All data was obtained as per the
IRB protocol and data was analyzed using Microsoft Excel
for Mac 2011 software. Statistical analyses were performed
using the Statistical Package for the Social Sciences (SPSS
version 16.0, Chicago, IL, USA). A review of the cytopa-
thology and surgical files from January 2008 through May
2013 at Weill Cornell Medical College was performed to
identify cases evaluated for a thyroid nodule. These cases
were generally performed with US guidance, although all
lesions undergoing FNA, whether US was used or not were
considered. Our inclusion criteria required that a FNA
diagnosis of Bethesda IIeVI be reported and subsequent IOF
section be performed. The FNA was correlated with the
locations of the resected nodule and of the nodule frozen
for intraoperative diagnosis. Our exclusion criteria included
nondiagnostic/unsatisfactory FNA samples (Bethesda I) and
incidental microcarcinomas.
IOF section specimen was classified as “negative” if the
pathologist reported “benign”, “follicular lesion”, or
“nodular hyperplasia”. IOF section was classified as positive
if malignancy was detected. FD was classified as either
benign or malignant. The FNA results for each case were
compared to the IOF section diagnosis and the FD. The
sensitivity and specificity of IOF section and FNA were
calculated with respect to the FD. The pathology charge at
WCMC for performing an IOF section is $251 per specimen,
including materials and professional fees only. Additional
costs were not considered. We assessed the cost-
effectiveness of performing an IOF section for thyroid
nodules by determining the additional pathology charge per
additional information provided.
IOF were performed by all pathologists, including the
head & neck pathologist, on a weekly basis. Head & neck
pathologist was consulted when available if other pathol-
ogists were on the IOF rotation.Results
There were a total of 1866 thyroid surgeries between
January 2008eMay 2013 performed at WCMC. A total of 578
thyroid surgical cases had IOF sections performed. Of these
cases, 435 met the inclusion criteria of having had an FNA
diagnosis of Bethesda IIeVI and subsequent IOF section
performed. Among the 435 patients, 311 (71%) were female
and 124 (29%) were male. The stratification of the FNA
diagnosis for these 435 cases was 149 (35%) Bethesda II, 170
(40%) Bethesda III, 91 (21%) Bethesda IV, 19 (4%) Bethesda
V, and 6 (100%) Bethesda 6 (Table 2). There were a total of
83 carcinomas identified on FD (Table 3). The final histology
results for the malignancies included 69 (83%) papillary
thyroid carcinomas (PTCs) (43 follicular variants, 19 classic,
3 oncocytic variants, 1 cribriform morular variant, 2 solid
variants, 1 diffuse sclerosing variant), 12 (14%) follicular
carcinomas, and 2 (2.4%) poorly differentiated carcinomas
(Table 3).
The preoperative FNA diagnosis for the 77 cases identi-
fied as carcinomas on FD were as follows: 11 (7.4%)
Bethesda II, 24 (14%) Bethesda III, 26 (29%) Bethesda IV, and
16 (84%) Bethesda V (Table 4). Of cases with a diagnosis
of Bethesda II by FNA, 7.4% were malignant on FD, yet only
1/149 (0.7%) were positive on IOF sections (Table 4, Fig. 1).
For Bethesda III cases, 14% were malignant on FD yet IOF
section suggested malignancy in only 5/170 (3%) of these
cases (Table 4, Fig. 1). 29% of cases with a Bethesda IV
Table 4 Diagnostic correlation of FNA, IOF section, and FD and types of carcinoma identified by IOF section.
Bethesda category No. of cases No. of cases
malignant
on FD
No. of cases
malignant on
IOF section
Diagnosis of malignant cases
identified on IOF section
II Benign 149 11 (7.4%) 1 (0.7%) 1 Classic PTC
III Atypia of undetermined significance
or follicular lesion of undetermined
significance
170 24 (14%) 5 (3%) 4 Classic PTC
1 Follicular variant PTC
IV Follicular neoplasm or suspicious
for a follicular neoplasm
91 26 (29%) 2 (1.1%) 1 Oncocytic PTC
1 Poorly differentiated carcinoma
V Suspicious for malignancy 19 16 (84%) 8 (42%) 4 Classic PTC
2 Follicular variant PTC
1 Cribriform morular variant PTC
1 Diffuse sclerosing variant PTC
VI Malignant 6 6 (100%) 6 (100%) 6 Classic PTC
Total 435 83 (19%) 22 (5%)
8 M.A. Cohen et al.diagnosis were positive on FD and only 2/91 (1.1%) were
positive on IOF sections (Table 4, Fig. 1). Among cases with
a FNA Bethesda V diagnosis, 84% were positive for malig-
nancy on FD, 8/19 (42%) of which were identified as ma-
lignant on IOF sections (Table 4, Fig. 1). IOF section thereby
contributed to the diagnosis of malignancy in 16/429 (4%)
cases by correctly suggesting malignancy (Table 4). The
final histology for these 16 cases included 9 (56%) classic
PTCs, 3 (19%) follicular variants of PTC, 1 (6.3%) cribriform
morular variant of PTC, 1 (6.3%) oncocytic variant of PTC,
1 (6.3%) poorly differentiated carcinoma, and 1 (6.3%)
diffuse sclerosing variant (Table 4). Excluding Bethesda V
lesions, IOF contributed to the diagnosis in 8/429 (1.9%) of
cases (Fig. 1).Fig. 1 Number of malignant cases identified by IOF section
for each Bethesda category. FD Z Malignant describes the
number of thyroid carcinomas identified upon final diagnosis.
IOF section Z Malignant describes the number of cases which
were identified to be malignant upon examination of IOF
sections.There were 61/77 (79%) false negatives on IOF and there
were no false positives on IOF section (Fig. 2). The speci-
ficity and sensitivity for malignancy of IOF section was 100%
and 21%, respectively. The additional pathology charge
alone per positive diagnosis by IOF section for the entire
cohort was $6730. The additional pathology charge alone
per positive diagnosis was $37,399 for Bethesda II, $8534 for
Bethesda III, $11,420 for Bethesda IV and $596 for Bethesda
V.Discussion
IOF section has traditionally been performed for thyroid
nodules for which an intraoperative diagnosis is critical in
deciding between a total thyroidectomy and lobectomy with
the potential to immediately alter the management plan.12
An intraoperative diagnosis of malignancy may help the sur-
geon avoid having to performa second completion procedure
while a benign diagnosis may help prevent unnecessary
complete removal of the gland.8 However, the frequency
with which IOF sections are performed for thyroid nodules
has decreased due to the high accuracy and specificity of FNA
in the diagnosis of papillary thyroid carcinoma and the
inability of neither FNA nor IOF section to reliably recognize
follicular andHu¨rthle cell carcinomas aswell as the follicular
variant of papillary carcinoma.8,13,14 In our cohort, the high
false negative IOF rate (79%) is related to those lesions
described as follicular lesion with deference to permanent
being ascribed asbenign; this demonstrates the challenges of
IOF for Bethesda IIeIV lesions. In addition, IOF sections have
also lost favor because they lead to the prolongation of OR
time, increased costs, and the possibility of an inaccurate
diagnosis that may misguide management.13
Previous studies of IOF section have noted other dis-
advantagesdespecially significant for thyroid lesions
measuring less than 1 cm in greatest dimensiondsuch as
sampling errors, introducing artifacts in the tissue, and
wasting specimen that may be necessary to make a final
diagnosis.12 Other opinions in the literature have reported
the lack of clinical utility of IOF section subsequent to an
FNA Bethesda diagnosis of follicular neoplasm, suspicious
Fig. 2 Diagnosis correlation of FNA, IOF section and FS.
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Meanwhile, some studies favor the use of IOF section to
confirm FNA diagnoses and to identify malignancies in pa-
tients with indeterminate or unsatisfactory FNA reports.1,11
Chang HY et al. noted that when there was a discrepancy
between the FNA and IOF section diagnosis for the same
case, the FS was more accurate (FS accuracy Z 78.9% vs.
FNA accuracy Z 21.1%).11 Other studies note that IOF
section may be particularly useful when it is positive for
malignancy because of reports of a false-positive rate as
low as 0%.10 FNA has recently been reported to have a
sensitivity for the detection of malignant thyroid nodules
ranging from 36% to 89% and a specificity ranging from 94%
to more than 99% with an overall diagnostic accuracy be-
tween 84% and 94%.The same studies reported a sensitivity,
specificity and accuracy for the ability of IOF section to
detect malignancy to be 56%e67%, 99%e100%, and 89%e
90%, respectively.1,10
Among a total of 1866 thyroid surgeries performed at our
institution over a five-year period, IOF section evaluation
was performed on 578 (31%) thyroid nodules. The present
study sought to evaluate the diagnostic utility of IOF sec-
tion for cases of nodular thyroid disease with a Bethesda
diagnosis of IIeVI at our institution. The percentage of
malignant cases that had a final histologic result of papil-
lary carcinoma in this series is similar to that previously
published (82% vs. 87% in a series of 704 thyroid carci-
nomas).8 IOF section was found to have a wider disparity
between its specificity and sensitivity (100% and 21%,
respectively) for identifying malignant thyroid lesions
compared to values reported in previous studies.1,10
Intraoperative evaluation correctly identified malignancy
in 16/429 (4%) of cases in this series. Half (8/16) of these
cases were classified as Bethesda V lesions prior to IOF
sections and thus, IOF contributed to the diagnosis of ma-
lignancy in only 8/410 (2.0%) of Bethesda IIeIV lesions. Such
data suggests that the potential of IOF section to alter thesurgical plan is limited outside of Bethesda V nodules. The
value of frozen section in benign nodules diagnosed on FNA
is also questionable due to a high false negative rate of 79%
(61/77). IOF section also appears to lack the ability to
reliably identify cases of follicular variant PTC, detecting
only 3/43 (7%) of this tumor type. Consequently, the charge
per IOF section added diagnosis of malignancy is highest in
the Bethesda II cohort ($37,399) and lowest for Bethesda V
nodules ($596). However, despite the lack of reliability of
diagnosis of Bethesda IIeIV lesions, some surgeons may
argue that any diagnoses discovered on frozen prove some
utility of this assessment. While this may be true, the
feasibility of a false positive on frozen section, which was
not encountered in our cohort, may limit this argument.
Further study, including formal cost effectiveness research
is necessary to answer this question.
The current study is not without limitations. Diagnostic
modalities such as FNA and IOF section are highly subjective
due to factors such as the heterogeneous nature of thyroid
pathologies and the inability of such modalities to reliably
detect malignancy in cases that are multifocal. Because all
FNAs and IOFs were not performed by the same clinician or
interpreted by a single pathologist, variables inherent to
the operator of the modality and the interpreter of the
results could not be controlled for. The pathologists who
interpreted the IOF sections were also not necessarily blind
to FNA diagnoses.
Conclusion
Our data indicates that IOF sections performed for cases
with a Bethesda diagnosis of IIeIV do not allow for a sig-
nificant improvement in diagnosis of malignancy. The role
of IOF section appears to be limited outside of Bethesda V
nodules and lacks the ability to reliably discern cases of
follicular variant PTC. IOF section should be likely be used
on a selective basis in the evaluation of thyroid nodules in
10 M.A. Cohen et al.order to maximize its clinical and cost utility. Improve-
ments in its sensitivity for detecting thyroid malignancies
and especially follicular variant PTCs would be needed to
justify its widespread use. Further research, including cost
effectiveness research is needed to answer this question.
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